Citius Oncology, Inc.

CTOR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4/A Dec 22, 2025 OWNERSHIP DOCUMENT
4/A Dec 22, 2025 OWNERSHIP DOCUMENT
4/A Dec 22, 2025 OWNERSHIP DOCUMENT
4/A Dec 22, 2025 OWNERSHIP DOCUMENT
4/A Dec 22, 2025 OWNERSHIP DOCUMENT
4/A Dec 22, 2025 OWNERSHIP DOCUMENT
4/A Dec 22, 2025 OWNERSHIP DOCUMENT
SCHEDULE 13D/A Dec 17, 2025
8-K Dec 10, 2025 CURRENT REPORT
424B5 Dec 10, 2025 PROSPECTUS SUPPLEMENT
8-K Dec 1, 2025 CURRENT REPORT
4/A Dec 1, 2025
4/A Dec 1, 2025
4/A Dec 1, 2025
4/A Dec 1, 2025
4/A Dec 1, 2025
4/A Dec 1, 2025
4/A Dec 1, 2025
4/A Dec 1, 2025
4/A Dec 1, 2025
4/A Dec 1, 2025
SCHEDULE 13G Nov 14, 2025
8-K Oct 27, 2025 CURRENT REPORT
8-K Oct 23, 2025 FORM 8-K
DEF 14A Sep 26, 2025 DEFINITIVE PROXY STATEMENT
← Newer Page 3 of 11 · 267 filings Older →